52.12000 USD
1.19
2.23%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
50.90000
53.57000
Previous close
53.31000
Open
53.34000
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
52.12
1.19
2.23%

Statistics

Valuation metrics
Market cap
10.01B
Enterprise value
9.37B
Trailing P/E (ttm)
19.37
Forward P/E
9.91
PEG ratio
-0.15
Price/Sales (ttm)
3.24
Price/Book (mrq)
1.65
Enterprise Value/Revenue
3.03
Enterprise Value/EBITDA
11.80
Overview
Shares outstanding
192.10M
Float
190.43M
Shares short
8.23M
% Held by insiders
0.77%
% Held by institutions
98.00%
Average volume (10 days)
1.88M
Average volume (90 days)
2.69M
Price summary
52-Week low
50.76
52-Week high
73.51
52-Week change
-25.75 -50.7%
Beta
0.30
50-Day moving average
53.77
200-Day moving average
58.45
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
16.82%
Operating margin
-6.02%
Operational effectiveness
Return on assets
6.15%
Return on equity
9.07%
Income statement
Revenue (ttm)
3.09B
Revenue per share (ttm)
16.17
Quarterly revenue growth (yoy)
4.10%
Gross profit (ttm)
2.52B
EBITDA
640.53M
Net income to common (ttm)
520.42M
Diluted EPS (ttm)
2.69
Quarterly earnings growth (yoy)
4.08%
Balance sheet
Total cash (mrq)
1.48B
Total cash per share (mrq)
7.69
Total debt (mrq)
604.24M
Total Debt/Equity (mrq)
9.98
Current ratio (mrq)
482.80%
Book value per share (mrq)
31.53
Cash flow
Cash flow statement
913.98M
Levered free cash flow (LFCF)
451.55M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 55 minutes

20:04
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).